Nvidia-backed AI drug developer Iambic is raising $150 million in U.S. IPO
The San Diego company's stock is expected to begin trading on Nasdaq Thursday under the ticker IAM, with the offering expected to close Friday
We haven't written up this one. Quartz has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Iambic, an AI drug discovery specialist, banks $150M in an IPO biopharmadive.com